Supriya Lifescience is well known in its manufacturing sector, they manufacture Active pharmaceutical ingredients (APIs). As per past details the company produces 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic. Supriya Lifescience outstands lot of other pharmaceutical companies as it owns a title of largest exporter of Salbutamol Sulphate from India in FY 2021.
Supriya Lifescience IPO, the subscription starts on Dec 16, 2021 and ends on Dec 20, 2021, IPO Price ranges from ₹265 to ₹274 per equity share with market lot of 54 market share, The issue size is aggregating up to ₹700.00 Cr with the equivalent price Rs.2 per share, and offer for sale is aggregating up to ₹500.00 Cr.
Supriya Lifescience IPO Timetable
Below IPO time table shows the IPO event details starting from IPO Open date to IPO Listing date
| Event | Date |
|---|---|
| IPO Open Date | Dec 16, 2021 |
| IPO Close Date | Dec 20, 2021 |
| Basis of Allotment Date | Dec 23, 2021 |
| Initiation of Refunds | Dec 24, 2021 |
| Credit of Shares to Demat Account | Dec 27, 2021 |
| IPO Listing Date | Dec 28, 2021 |
Supriya Lifescience IPO Lot Size Details
This below table shows how the shares will be alloted to the investors.
| IPO Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 54 | ₹14,796 |
| Maximum | 13 | 702 | ₹192,348 |
Supriya Lifescience IPO Allotment Status
Allotment will be done after the IPO dates are closed, as of now investors can plan for the investments, on Dec 23 the allotment procedure starts. Stay tuned here in StockIPO to get updates on Supriya Lifescience IPO allotment.
Supriya Lifescience IPO Reviews
So far Supriya has made good growth by exporting over 75% of products for more than 86 contries, these many years were very fruitfull for them, considering thier growth chart, they are fundamentally strong and stand unique compared to any other pharmaceutical companies.
Also check other Upcoming IPO
